Tuesday, March 21, 2023 | Back issues
Courthouse News Service Courthouse News Service

BioPharm Merger

WILMINGTON, Del. - BioClinica is selling itself too cheaply to JLL Partners, for $7.25 a share or $123 million, shareholders claim in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.